Lactylated histone H3K18 as a potential biomarker for the diagnosis and prediction of the severity of pancreatic cancer.

MLA

Hou, Jinping, et al. “Lactylated Histone H3K18 as a Potential Biomarker for the Diagnosis and Prediction of the Severity of Pancreatic Cancer.” Clinics (Sao Paulo, Brazil), vol. 80, Nov. 2024, p. 100544. EBSCOhost, https://doi.org/10.1016/j.clinsp.2024.100544.

APA

Hou, J., Guo, M., Li, Y., & Liao, Y. (2024). Lactylated histone H3K18 as a potential biomarker for the diagnosis and prediction of the severity of pancreatic cancer. Clinics (Sao Paulo, Brazil), 80, 100544. https://doi.org/10.1016/j.clinsp.2024.100544

Chicago

Hou, Jinping, Mingsong Guo, Yongqiong Li, and Yijin Liao. 2024. “Lactylated Histone H3K18 as a Potential Biomarker for the Diagnosis and Prediction of the Severity of Pancreatic Cancer.” Clinics (Sao Paulo, Brazil) 80 (November): 100544. doi:10.1016/j.clinsp.2024.100544.